Pharming Group N.V (PHAR) Return on Sales: 2021-2025
Historic Return on Sales for Pharming Group N.V (PHAR) over the last 4 years, with Sep 2025 value amounting to 0.43%.
- Pharming Group N.V's Return on Sales rose 53.00% to 0.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.43%, marking a year-over-year increase of 53.00%. This contributed to the annual value of -0.04% for FY2024, which is 3.00% down from last year.
- According to the latest figures from Q3 2025, Pharming Group N.V's Return on Sales is 0.43%, which was up 3,495.78% from 0.01% recorded in Q2 2025.
- Pharming Group N.V's 5-year Return on Sales high stood at 0.43% for Q3 2025, and its period low was -0.16% during Q3 2021.
- In the last 3 years, Pharming Group N.V's Return on Sales had a median value of -0.09% in 2024 and averaged -0.02%.
- Its Return on Sales has fluctuated over the past 5 years, first fell by 25bps in 2023, then skyrocketed by 53bps in 2025.
- Pharming Group N.V's Return on Sales (Quarterly) stood at 0.03% in 2021, then rose by 14bps to 0.17% in 2022, then fell by 25bps to -0.09% in 2023, then remained steady at -0.09% in 2024, then spiked by 53bps to 0.43% in 2025.
- Its Return on Sales stands at 0.43% for Q3 2025, versus 0.01% for Q2 2025 and -0.09% for Q4 2024.